By using WellRx, you accept our Privacy Policy (including the CA Privacy Act policy if you are a CA resident), including our collection of data and use of cookies.

  • No image available for this medication
    • ENSPRYNG

    • QTY 1
    • 120 MG/ML
    • Syringe
    • Near  77381

SATRALIZUMAB (sat ra LIZ ue mab) treats neuromyelitis optica spectrum disorder (NMOSD), a condition that causes inflammation in the nerves of the eyes and spinal cord. It works by decreasing inflammation. It is a monoclonal antibody.


There is no lifestyle interaction information available for this medication.